Novel Fluorophore Helps Reduce Surgical Risk in Patients Undergoing Prostatectomy
Impossible d'ajouter des articles
Désolé, nous ne sommes pas en mesure d'ajouter l'article car votre panier est déjà plein.
Veuillez réessayer plus tard
Veuillez réessayer plus tard
Échec de l’élimination de la liste d'envies.
Veuillez réessayer plus tard
Impossible de suivre le podcast
Impossible de ne plus suivre le podcast
Novel Fluorophore Helps Reduce Surgical Risk in Patients Undergoing Prostatectomy
-
Lu par :
-
De :
À propos de ce contenu audio
In this episode, host Rick Greene, MD, FACS, talks with Samuel A. Gold, MD, from the urology service in the Department of Surgery at Memorial Sloan Cancer Center in New York, New York, about using intraoperative fluorescence to illuminate nerve structures during robotic-assisted prostatectomy. Dr. Gold’s phase-1 study, published in JAMA Surgery (Rizedisben in Minimally Invasive Surgery), found that the fluorophore was generally well tolerated and clinically effective, which could revolutionize prostatic surgery and lead to wider applicability.
Talk about the podcast on social media using the hashtag #SurgicalReadings
adbl_web_anon_alc_button_suppression_c
Aucun commentaire pour le moment
